secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001404644-24-000066
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene shareholders elect both director nominees and approve advisory votes at 2024 annual meeting
--------------------------------------------------------------------------------

- Cory Freedland and Rachel McMinn elected as Class I directors with ~9.2M votes for each.
- Advisory say-on-pay approved: 9,092,990 for, 482,023 against, 5,878 abstain.
- Ratification of Deloitte & Touche as auditor for FY2024 passed with 9,826,384 votes for.
- Quorum achieved with 9,829,572 shares (76.4% of voting power) present at June 14, 2024 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000066/0001404644-24-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464424000066/ngne-20240614.htm
  HTML page:      https://secwatch.observer/filing/0001404644-24-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer